Stay updated with breaking news from Ned Berkowitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- New data released today by the National Foundation for Infectious Diseases (NFID) showed that 44 percent of US adults are unsure or do not plan...
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Share this article Share this article BETHESDA, Md., Feb. 4, 2021 /PRNewswire/ -- New data released today by the National Foundation for Infectious Diseases (NFID) shows a significant gap in vaccine confidence among Black adults in the US. Despite bearing a disproportionate burden of serious disease and death related to COVID-19 and influenza (flu), a large percentage of Black adults say they will not get a COVID-19 vaccine when eligible, and they are either unsure or will not get a flu vaccine this season. Patricia N. Whitley-Williams, MD, President of the National Foundation for Infectious...
Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis -- Klisyri® (tirbanibulin) is a novel microtubule inhibitor, indicated for the topical treatment of actinic keratosis (AK) on the face or scalp -- Actinic keratosis is the second most common diagnosis made by dermatologists in the United States1 -- In one of the largest Phase III clinical study programs2 ever conducted for a topical AK treatment, tirbanibulin demonstrated complete clearance of actinic keratosis lesions at day 57 in treated face or scalp areas in a significant...